Efficacy of targeted therapy of environmental mastitis using on-farm culturing in small dairy herds

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027014%3A_____%2F24%3A10005922" target="_blank" >RIV/00027014:_____/24:10005922 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/62157124:16170/24:43881756

Výsledek na webu

<a href="https://actavet.vfu.cz/93/1/0003/" target="_blank" >https://actavet.vfu.cz/93/1/0003/</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2754/avb202493010003" target="_blank" >10.2754/avb202493010003</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Efficacy of targeted therapy of environmental mastitis using on-farm culturing in small dairy herds

Popis výsledku v původním jazyce

The aim of the study was to evaluate treatment protocols for improvement of clinical and bacteriological cure rate of non-severe clinical mastitis (CM) and selective dry cow therapy (SDCT). Mastitis management based on on-farm commercial culture system MicroMastTM and data analysis were implemented into two dairy herds. Quarters with evidence of Gram-positive agents were treated using benzyl penicillin or amoxicillin and/or by amoxicillin with clavulanic acid. In herd A, 31 quarters of non-severe CM were recorded. Of them, Streptococcus uberis was isolated in 16 (51.6%), non-aureus staphylococci (NAS) in 8 (25.8%), E. coli in 5 (16.1%) and no growth in 2 (6.5%) cases. Bacteriological cure was observed in 24/29 (82.8%) quarters. Antimicrobial consumption was reduced from 3.56 to 2.33 doses per case. Under the SDCT protocol, 28 quarters (13.2%) of 53 cows dried-off were included, achieving a reduction by 86.8% on the quarter level. In herd B, 23 quarters of non-severe CM were recorded. Of them, S. uberis and Escherichia coli were identified equally in 8 (34.8%) samples and NAS in 2 (8.7%) samples and with no growth in 5 (21.7%) cases. Bacteriological cure was achieved in 17/18 quarters (94.4%). Antimicrobial consumption was reduced from 4.45 to 1.83 doses per case. Only 5 (1.7%) quarters of 72 cows were included for SDCT with reduction in consumption of antimicrobials by 98.3% on the quarter level. In summary, innovated treatment protocols based on results of on-farm culture enabled a significant reduction of antimicrobial consumption and improvement of bacteriological cure rate in conditions of practise.

Název v anglickém jazyce

Efficacy of targeted therapy of environmental mastitis using on-farm culturing in small dairy herds

Popis výsledku anglicky

The aim of the study was to evaluate treatment protocols for improvement of clinical and bacteriological cure rate of non-severe clinical mastitis (CM) and selective dry cow therapy (SDCT). Mastitis management based on on-farm commercial culture system MicroMastTM and data analysis were implemented into two dairy herds. Quarters with evidence of Gram-positive agents were treated using benzyl penicillin or amoxicillin and/or by amoxicillin with clavulanic acid. In herd A, 31 quarters of non-severe CM were recorded. Of them, Streptococcus uberis was isolated in 16 (51.6%), non-aureus staphylococci (NAS) in 8 (25.8%), E. coli in 5 (16.1%) and no growth in 2 (6.5%) cases. Bacteriological cure was observed in 24/29 (82.8%) quarters. Antimicrobial consumption was reduced from 3.56 to 2.33 doses per case. Under the SDCT protocol, 28 quarters (13.2%) of 53 cows dried-off were included, achieving a reduction by 86.8% on the quarter level. In herd B, 23 quarters of non-severe CM were recorded. Of them, S. uberis and Escherichia coli were identified equally in 8 (34.8%) samples and NAS in 2 (8.7%) samples and with no growth in 5 (21.7%) cases. Bacteriological cure was achieved in 17/18 quarters (94.4%). Antimicrobial consumption was reduced from 4.45 to 1.83 doses per case. Only 5 (1.7%) quarters of 72 cows were included for SDCT with reduction in consumption of antimicrobials by 98.3% on the quarter level. In summary, innovated treatment protocols based on results of on-farm culture enabled a significant reduction of antimicrobial consumption and improvement of bacteriological cure rate in conditions of practise.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

40201 - Animal and dairy science; (Animal biotechnology to be 4.4)

Projekt

<a href="/cs/project/QK21020304" target="_blank" >QK21020304: Vliv úrovně managementu chovu a prevence chorob hospodářských zvířat, včetně biosecurity na snížení spotřeby antimikrobiálních látek a šíření antimikrobiální rezistence</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Acta Veterinaria Brno

ISSN

0001-7213

e-ISSN

—

Svazek periodika

93

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

8

Strana od-do

3-10

Kód UT WoS článku

001199853700009

EID výsledku v databázi Scopus

2-s2.0-85186556696